Publication
SARS-CoV-2 immunization index in the academic community: a retrospective post-vaccination study
| dc.contributor.author | Oliveira, Ketlyn | |
| dc.contributor.author | Almeida, Ana | |
| dc.contributor.author | Silva, Carina | |
| dc.contributor.author | Brito, Miguel | |
| dc.contributor.author | Ribeiro, Edna | |
| dc.date.accessioned | 2024-12-11T09:55:25Z | |
| dc.date.available | 2024-12-11T09:55:25Z | |
| dc.date.issued | 2024-11 | |
| dc.description | This work was supported by Project COVID management and acquired immunity assessment in the IPL community (COVIDVax_IPL) funded by Instituto Politécnico de Lisboa (IPL). H&TRC authors gratefully acknowledge the FCT/MCTES UIDP/05608/2020, and UIDB/05608/2020). | pt_PT |
| dc.description.abstract | Background/Objectives: The COVID-19 pandemic has revolutionized vaccine production and compelled a massive global vaccination campaign. This study aimed to estimate the positivity and levels of SARS-CoV-2 IgG antibodies acquired due to vaccination and infection in the academic population of a Portuguese university. Methods: Blood samples were collected and analyzed using the ELISA methodology, and statistical analysis was performed. Results: A total of 529 volunteers with at least one dose of the vaccine were enrolled in this study. Individuals without a prior COVID-19 diagnosis were divided into two groups: 350, who received a full vaccination, and 114, who received a full vaccination and a booster dose of the same vaccine (81) and mixed vaccines (33). Regarding the individuals who reported a prior SARS-CoV-2 infection, 31 received a full vaccination, and 34 received only one vaccination dose. Data analysis showed a higher level of IgG against SARS-CoV-2 in younger, female individuals who received the Moderna vaccine, with recent post-vaccine administration, a mixed booster dose, and prior SARS-CoV-2 infection. Conclusions: Assessing vaccination’s effectiveness and group immunity is crucial for pandemic management, particularly in academic environments with high individual mobility, to define groups at risk and redirect infection control strategies. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Oliveira K, Almeida A, Silva C, Brito M, Ribeiro E. SARS-CoV-2 immunization index in the academic community: a retrospective post-vaccination study. Infect Dis Rep. 2024;16(6):1084-97. | pt_PT |
| dc.identifier.doi | 10.3390/idr16060088 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.21/18006 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.relation.publisherversion | https://www.mdpi.com/2036-7449/16/6/88 | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | pt_PT |
| dc.subject | SARS-CoV-2 | pt_PT |
| dc.subject | Immunity | pt_PT |
| dc.subject | Vaccines | pt_PT |
| dc.subject | Academic community | pt_PT |
| dc.subject | Immunological variables | pt_PT |
| dc.subject | FCT_UIDP/05608/2020 | pt_PT |
| dc.subject | FCT_UIDB/05608/2020 | pt_PT |
| dc.title | SARS-CoV-2 immunization index in the academic community: a retrospective post-vaccination study | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 1097 | pt_PT |
| oaire.citation.issue | 6 | pt_PT |
| oaire.citation.startPage | 1084 | pt_PT |
| oaire.citation.title | Infectious Disease Reports | pt_PT |
| oaire.citation.volume | 16 | pt_PT |
| person.familyName | Almeida | |
| person.familyName | Silva | |
| person.familyName | Brito | |
| person.familyName | Ribeiro | |
| person.givenName | Ana | |
| person.givenName | Carina | |
| person.givenName | Miguel | |
| person.givenName | Edna | |
| person.identifier | 2405257 | |
| person.identifier.ciencia-id | 0116-985F-3D81 | |
| person.identifier.ciencia-id | 2411-5936-0820 | |
| person.identifier.ciencia-id | 231F-F341-7E93 | |
| person.identifier.ciencia-id | C414-CDF2-D35A | |
| person.identifier.orcid | 0000-0003-4984-0759 | |
| person.identifier.orcid | 0000-0003-1021-7935 | |
| person.identifier.orcid | 0000-0001-6394-658X | |
| person.identifier.orcid | 0000-0003-1316-7750 | |
| person.identifier.rid | E-6523-2019 | |
| person.identifier.rid | A-7970-2016 | |
| person.identifier.scopus-author-id | 57191899755 | |
| person.identifier.scopus-author-id | 55258764900 | |
| person.identifier.scopus-author-id | 35224551000 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 6adcdd33-b852-4e90-b4b0-551dfc0d8fb9 | |
| relation.isAuthorOfPublication | 81a5cd80-1982-43ba-bde5-4c43ae0e5234 | |
| relation.isAuthorOfPublication | 4252d8e0-800c-4d67-8b13-0b711d860669 | |
| relation.isAuthorOfPublication | a571bf34-bcda-49ca-b5cb-4cdecbb3d9c7 | |
| relation.isAuthorOfPublication.latestForDiscovery | a571bf34-bcda-49ca-b5cb-4cdecbb3d9c7 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- SARS-CoV-2 immunization index in the academic community_a retrospective post-vaccination study.pdf
- Size:
- 1.16 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
